Monday, 17 April 2023
A new pan-industry group, the first of its kind worldwide, has been formed to tackle the increasing threat that wormer resistance poses to horse health and the equine industry. Termed CANTER to communicate the urgency of its crusade, Controlling ANTiparasitic resistance in Equines Responsibly brings together voluntary representation from the widest reaches of the sector. These include leading experts in the field across prescribers, diagnostic providers, pharmaceutical companies, trade organisations, technical experts, horse owners, charities, and policy makers. All recognise the critical consequences of antiparasitic resistance and the need for coordinated action to slow the development and maintain efficacy of our limited treatments.
It recognises that antiparasitic resistance (AR) in equine parasites has critical health, welfare and husbandry consequences and coordinated action is essential to maintain future antiparasitic efficacy and slow the development and spread of AR. CANTER’s initial focus is resistance in equine internal parasites.
CANTER was formed subsequent to several stakeholder engagement events to discuss the present problem of AR in equine internal parasites with representatives from across the equine industry. These events resulted in positive and collaborative discussions on how to progress solutions to tackle this critical issue and there was much enthusiasm and support for industry-wide action and follow on activities.
The CANTER core steering group comprises of approximately 20 representatives from across the equine sector with an active interest in the sustainable control of parasites in equines. Many organisations contributed to the development of CANTER including:
CANTER aims to lead a coordinated approach to antiparasitic use and stewardship to combat AR in equine parasites in the UK. It will:
For more information, head over to their website: www.canterforhorses.org.uk